Zydus Lifesciences informs about press release

22 Jul 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated July 22, 2024 titled ‘Zydus receives approval from COFEPRIS of Mexico to market Bhava™ (Bevacizumab biosimilar) to treat various cancers’.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

916.55 -5.45 (-0.59%)
12-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.00
Dr. Reddys Lab 1318.75
Cipla 1325.25
Zydus Lifesciences 916.55
Lupin 2356.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×